Skip to content
For research use only. Not for human or veterinary use. Not a drug, food, or dietary supplement.
AMIRAVOResearch Library
Cycle-length evidence

Selank cycle length: what human studies ran

Approved outside the USBLimited human data
Short answer: there is no established Selank cycle length, and we found no human studies that report one.

Treatment and follow-up in human studies

No human study durations are recorded.

What has not been tested

  • On-and-off schedules or breaks between courses.
  • Repeated courses and long-term exposure beyond the periods listed.
  • Selank combined with other compounds, unless a study above says so.

Frequently asked questions

Is there an established Selank cycle length?
No. We found no human studies that report a treatment duration for Selank.
What is the longest human study of Selank?
None is recorded.
Do study durations tell me how long to use something?
No. A study duration is how long investigators administered a compound to selected participants under monitoring. It is not a recommended course, and a break between courses has not been tested for any compound on this site that is not approved.
Selank dosing reference Full research page

References

  1. Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity Protein Pept Lett. 2018
  2. Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission Front Pharmacol. 2016
  3. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2008
  4. Immunomodulatory effects of selank in patients with anxiety-asthenic disorders (in Russian) Zh Nevrol Psikhiatr Im S S Korsakova. 2008
  5. Naloxone-blocked depriming effect of anxiolytic selank on apomorphine-induced behavioral manifestations of hyperfunction of dopamine system Bull Exp Biol Med. 2006
  6. Development of Peptide Biopharmaceuticals in Russia Pharmaceutics. 2022
  7. DailyMed drug-label search for selank (conducted for this entry) FDA DailyMed. 2026
  8. WADA International Standard: Prohibited List 2026 (S0 and S2.2) WADA Prohibited List. 2026
  9. PubChem CID 11765600 (Selank) PubChem. 2026
  10. Comparison of pharmacological effects of heptapeptide selank after intranasal and intraperitoneal administration to BALB/c and C57BL/6 mice (in Russian) Eksp Klin Farmakol. 2016
  11. ClinicalTrials.gov intervention search for selank (conducted for this entry) ClinicalTrials.gov. 2026